Streaming Well has expanded its senior creative team, adding Steve Skinner (pictured above right) as creative director and Freddie Slaughter (above left) as senior producer and account mana
Sarepta Therapeutics has decided not to continue the development of vesleteplirsen, a follow-up to its Duchenne muscular dystrophy (DMD) therapy Exondys 51.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.